Last reviewed · How we verify
NCT04722770
Clinical Development of Deep Learning for the OtoSight
trial testing PhotoniCare OtoSight Middle Ear Scope in Otitis Media Acute in 188 participants. Completed in 31 August 2023.
2 September 2022
Quick facts
| Lead sponsor | PhotoniCare, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 188 |
| Start date | 19 January 2021 |
| Primary completion | 2 September 2022 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PhotoniCare OtoSight Middle Ear Scope
Conditions studied
- Otitis Media Acute — all drugs for Otitis Media Acute →
Sponsor
PhotoniCare, Inc.
Who can join
Adults 6 Months to 4, any sex, with Otitis Media Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to clinically develop and evaluate a machine learning approach to improve the performance and data interpretation of the PhotoniCare OtoSight Middle Ear Scope in pediatric patients presenting at the primary care office for suspected ear infections. In this observational study, results of OtoSight imaging will not affect patient standard of care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04722770
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Otitis Media Acute
Currently open trials in the same condition.
- NCT06285812 — Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children · active not recruiting
Other PhotoniCare, Inc. trials
Trials by the same sponsor.
- NCT06285812 — Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children · active not recruiting
- NCT03890107 — Clinical Evaluation of the OtoSight · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04722770 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PhotoniCare, Inc.
- Last refreshed: 23 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04722770.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing